These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 28035723)

  • 1. Tacrolimus improves proteinuria remission in adults with cyclosporine A-resistant or -dependent minimal change disease.
    Xu D; Gao X; Bian R; Mei C; Xu C
    Nephrology (Carlton); 2017 Mar; 22(3):251-256. PubMed ID: 28035723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tacrolimus versus intravenous pulse cyclophosphamide therapy in Chinese adults with steroid-resistant idiopathic minimal change nephropathy: a multicenter, open-label, nonrandomized cohort trial.
    Li H; Shi X; Shen H; Li X; Wang H; Li H; Xu G; Chen J
    Clin Ther; 2012 May; 34(5):1112-20. PubMed ID: 22503105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tacrolimus therapy in adults with steroid- and cyclophosphamide-resistant nephrotic syndrome and normal or mildly reduced GFR.
    Li X; Li H; Ye H; Li Q; He X; Zhang X; Chen Y; Han F; He Q; Wang H; Chen J
    Am J Kidney Dis; 2009 Jul; 54(1):51-8. PubMed ID: 19406543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of tacrolimus versus cyclosporine in children with steroid-resistant nephrotic syndrome: a randomized controlled trial.
    Choudhry S; Bagga A; Hari P; Sharma S; Kalaivani M; Dinda A
    Am J Kidney Dis; 2009 May; 53(5):760-9. PubMed ID: 19268410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tacrolimus as the first-line agent in adult-onset minimal change disease: A randomized controlled study.
    Patil MR; Divyaveer SS; Raychaudhary A; Trivedi M; Mahajan C; Sarkar D; Pandey R
    Saudi J Kidney Dis Transpl; 2019; 30(1):129-137. PubMed ID: 30804274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term ciclosporine A treatment in adults with minimal change nephrotic syndrome or focal segmental glomerulosclerosis.
    Ittel TH; Clasen W; Fuhs M; Kindler J; Mihatsch MJ; Sieberth HG
    Clin Nephrol; 1995 Sep; 44(3):156-62. PubMed ID: 8556831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of cyclosporine a for patients with steroid-resistant nephrotic syndrome: a meta-analysis.
    Li HY; Zhang X; Zhou T; Zhong Z; Zhong H
    BMC Nephrol; 2019 Oct; 20(1):384. PubMed ID: 31646979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of focal and segmental glomerulosclerosis in adults with tacrolimus monotherapy.
    Duncan N; Dhaygude A; Owen J; Cairns TD; Griffith M; McLean AG; Palmer A; Taube D
    Nephrol Dial Transplant; 2004 Dec; 19(12):3062-7. PubMed ID: 15507477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term results of cyclosporine-induced remission of relapsing nephrotic syndrome in children.
    Kim PK; Kim KS; Pai KS; Kim JH; Choi IJ
    Yonsei Med J; 1997 Oct; 38(5):307-18. PubMed ID: 9409194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tacrolimus as a steroid-sparing agent for adults with steroid-dependent minimal change nephrotic syndrome.
    Li X; Li H; Chen J; He Q; Lv R; Lin W; Li Q; He X; Qu L; Suya W
    Nephrol Dial Transplant; 2008 Jun; 23(6):1919-25. PubMed ID: 17911091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience.
    El-Husseini A; El-Basuony F; Mahmoud I; Sheashaa H; Sabry A; Hassan R; Taha N; Hassan N; Sayed-Ahmad N; Sobh M
    Nephrol Dial Transplant; 2005 Nov; 20(11):2433-8. PubMed ID: 16204303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adult minimal-change disease: clinical characteristics, treatment, and outcomes.
    Waldman M; Crew RJ; Valeri A; Busch J; Stokes B; Markowitz G; D'Agati V; Appel G
    Clin J Am Soc Nephrol; 2007 May; 2(3):445-53. PubMed ID: 17699450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tacrolimus improves the proteinuria remission in patients with refractory IgA nephropathy.
    Zhang Q; Shi SF; Zhu L; Lv JC; Liu LJ; Chen YQ; Zhang H; Wang HY
    Am J Nephrol; 2012; 35(4):312-20. PubMed ID: 22456060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of tacrolimus or cyclosporine A in children with idiopathic nephrotic syndrome.
    Wang W; Xia Y; Mao J; Chen Y; Wang D; Shen H; Fu H; Du L; Liu A
    Pediatr Nephrol; 2012 Nov; 27(11):2073-2079. PubMed ID: 22714672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized, Controlled Trial of Tacrolimus and Prednisolone Monotherapy for Adults with
    Medjeral-Thomas NR; Lawrence C; Condon M; Sood B; Warwicker P; Brown H; Pattison J; Bhandari S; Barratt J; Turner N; Cook HT; Levy JB; Lightstone L; Pusey C; Galliford J; Cairns TD; Griffith M
    Clin J Am Soc Nephrol; 2020 Feb; 15(2):209-218. PubMed ID: 31953303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tacrolimus as rescue therapy for adult-onset refractory minimal change nephrotic syndrome with reversible acute renal failure.
    Li X; Xu N; Li H; Han F; Wang R; He Q; He X; Chen J
    Nephrol Dial Transplant; 2013 Sep; 28(9):2306-12. PubMed ID: 23787554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of steroid-resistant nephrotic syndrome with cyclosporine: study of 17 cases and a literature review.
    Frassinetti Castelo Branco Camurça Fernandes P; Bezerra Da Silva G; De Sousa Barros FA; Costa Oliveira CM; Kubrusly M; Evangelista JB
    J Nephrol; 2005; 18(6):711-20. PubMed ID: 16358229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term Cyclosporine A (Sandimmun) therapy for steroid resistant nephrotic syndrome in children.
    Sancewicz-Pach K; Słowiaczek E; Kwinta-Rybicka J; Wilkosz K; Drozdz D; Nowak J
    Przegl Lek; 1996; 53(4):365-8. PubMed ID: 8711193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of sirolimus plus tacrolimus versus sirolimus plus cyclosporine in high-risk renal allograft recipients: results from an open-label, randomized trial.
    Gaber AO; Kahan BD; Van Buren C; Schulman SL; Scarola J; Neylan JF;
    Transplantation; 2008 Nov; 86(9):1187-95. PubMed ID: 19005398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tacrolimus versus cyclophosphamide in steroid-dependent or steroid-resistant focal segmental glomerulosclerosis: a randomized controlled trial.
    Ren H; Shen P; Li X; Pan X; Zhang W; Chen N
    Am J Nephrol; 2013; 37(1):84-90. PubMed ID: 23343906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.